We report on gene therapy for Wiskott-Aldrich syndrome, a breakthrough treatment showing promising results in clinical trials (NCT03537496), with 90% efficacy rates, now available at top US hospitals.
We report on gene therapy for Wiskott-Aldrich syndrome, a breakthrough treatment showing promising results in clinical trials (NCT03537496), with 90% efficacy rates, now available at top US hospitals.
“Breakthrough gene therapy bubble boy disease treatment shows promise in rebuilding immune systems from scratch, offering new hope”